Skip to main content
. Author manuscript; available in PMC: 2022 Jul 13.
Published in final edited form as: Oncogene. 2022 Jan 13;41(7):921–929. doi: 10.1038/s41388-021-02145-1

Table 1.

Role of cellular oncogenes in immune evasion.

Oncogene Role in Immune Evasion References
ALK Inhibits immunogenic cell death (63, 64)
β-catenin Represses the expression of CCL4, which recruits DCs and T cells (57)
BRAF Drives internalization and sequestration of MHC-I (80, 81)
EGFR Contributes to increased PD-L1 expression (83, 102)
EPHA2 Increases TGFB signaling and COX-2 expression, causing increased proinflammatory PGE2 (56)
FGFR Drives PD-L1 expression (104)
HER2 Binds to STING to prevent immune sensing
Internalization of MHC-I
(40, 41, 82)
MYC Induces expression of CCL9 to recruited macrophages
Acts with KRAS to upregulate IL-23 to suppress innate immune cells and reduce CTL infiltration
Drives PD-L1 expression
Inhibits immunogenic cell death
(49, 58, 59, 103)
NOTCH Suppresses SASP, causing decreased T cell recruitment (67)
RAS Drives OIS and SASP expression (51, 58, 59, 105)
SMAD4 Drives TGFB signaling, which inhibits adaptive immune response (56)